Prime Fund Recommendation: 3 balanced advantage funds for your portfolio

Investors, typically, want three things from their investments – low risk, good returns, and low taxes. Now, no mutual fund will tick all three boxes at the same time. So you need to prioritize. And in these current times, if you prioritize moderating risk and tax efficiency, then balanced advantage funds can come in useful.

Prime Fund Recommendation: 3 balanced advantage funds for your portfolio

Balanced advantage funds versus Balanced hybrid funds

With the wide coverage of balanced hybrid funds in recent times in media, let us make a clear distinction in our stance between the two first.

Balanced advantage funds (or dynamic asset allocation funds), as most of you would know, combine equity and debt and use derivatives to offset equity exposure and therefore reduce equity risk. Tax efficiency comes from their equity taxation, which sees long-term capital gains above Rs 1 lakh taxed at 10%. We’ve explained how these funds work in several earlier articles, so we won’t get into that here. These funds sit below aggressive hybrid and above equity savings funds in terms of risk and return.

There’s also a new set of hybrid funds that have recently launched – balanced hybrid funds. Balanced hybrid funds will generally come from new AMCs, as SEBI rules mandate that an AMC can have either an aggressive hybrid fund or a balanced hybrid fund most older AMCs will already have the former). Balanced hybrid funds can have equity allocation between 40-60% with the remaining in debt and derivatives are not allowed. These funds would offer indexation benefits on long-term capital gains (as debt funds used to earlier). As debt funds have lost their indexation benefit, this category has more recently come into the limelight and is being picked by AMCs as a new fund, if they do not already have an aggressive hybrid fund.

Given that there is no return history for these funds, it is not possible to know how they deliver. But even so, there is minimal reason to go for balanced hybrid funds as equity savings and balanced advantage would be better at containing downsides owing to their hedging, aggressive hybrid funds would score on upsides, and all three would offer better taxation. Therefore, we wouldn’t recommend balanced hybrid funds yet.

How to use balanced advantage funds

Coming back to balanced advantage funds – overall, these funds are lower-risk routes to investing in equity and can be held by any investor with a timeframe of at least 2 years. However, in these current times, you may be specifically wondering if you should add them now. Here are a few pointers on how you can use these funds in your portfolio.

  • As a diversifier: If you have a large-sized portfolio, balanced advantage funds can be a good way to diversify your portfolio away from pure equity or pure debt, and offer better-than-debt returns without equity risk. 
  • For tax efficiency: For those in the 15% and higher tax brackets, part of debt allocation in a portfolio can instead go towards these funds. Do not replace entire debt allocation – debt funds are lower risk, bring in better downside containment, and diversify your portfolio away from equity. Do not also exit debt investments already made for the sake of investing in balanced advantage funds. Invest only additional money. Also, if you hold debt funds for income generation (for example, through SWPs) don’t substitute with balanced advantage funds. These funds need at least 1.5-2 years in holding period before you can make any withdrawals.
  • To reduce risk now: In the current market scenario, your portfolio could be high on equity or have a high allocation to aggressive mid/smallcap oriented funds. If you have a surplus to invest, you can make fresh investments in balanced advantage funds. This will help you avoid further increasing equity exposure in volatile times without having to exit equity funds. You can, for example, temporarily divert SIP amounts to these funds until your allocations are more in line with what is ideal for your risk and timeframe. For this purpose, ensure that you choose a conservatively-run balanced advantage fund (see recommendation below), else it would defeat the purpose of reducing risk.
  • For nervous investors: For all those of you who are worried about current market conditions, fresh investments can be made in balanced advantage funds if you want to continue to participate in equity but are wary of corrections. Here too, go for conservative-style funds.

The difference in funds

Funds in the balanced advantage category use quantitative indicators to decide direction, volatility and therefore how much to hedge. Typically, these would be index valuations, technical indicators, institutional flows, and so on. However, the manner in which these metrics are used in terms of market indication and the strategy to be adopted varies with each fund.

Therefore, funds in the category are not uniform in the extent to which derivatives form part of the portfolio and the change in derivatives in response to market cycles. This makes the risk and return profiles of each fund different from the other. Conservatively-managed funds tend to maintain higher hedging and do not see big swings in derivative allocation. Aggressively-managed funds can have very low to no hedging, or then can drastically shift their hedging based on market cycles. 

For example, consider the earlier Nifty 50 peak in December 2022. At the time, the net equity (unhedged equity) varied from 32% to 80%, with the average at 56%. The following months saw the Nifty 50 marginally correcting, sending the average net equity dropping to 53% and then back up to 57% by April 2023. This apart, given that falling markets offer more buying opportunities, a few funds which had hedged heavily quickly upped their net equity. But those that were already aggressive and kept hedging very low had to do the opposite.

Therefore, while the former set of funds may have shown comparatively lower returns in the run up to the peak, they would have contained downsides better. The latter set of aggressive funds would have delivered well but would have had to move quickly to contain losses in market falls and, in very steep corrections, these funds would have slipped into bigger losses. In the 2020 correction, for instance, 1-month losses were as deep as 20-30%. It’s important, thus, to know how aggressive a fund is before you add it to your portfolio. 
In Prime Funds, our hybrid recommendations are split into Low Risk and Moderate Risk. Low Risk funds comprise conservatively-run balanced advantage funds, plus arbitrage and equity savings funds. Moderate risk funds house the aggressively-run balanced advantage funds and the normal aggressive hybrid funds.

Prime Fund recommendations

Here is explaining the 3 balanced advantage funds currently recommended in Prime Funds, in both the Low-Risk and Moderate-Risk buckets. Please read the suitability of each fund and decides which ones fit your portfolio, if they do.

#1 ICICI Pru Balanced Advantage

ICICI Pru Balanced Advantage is in the Hybrid – Low Risk bucket in Prime Funds. Among our Prime Funds recommendations in the balanced advantage category, this fund has the lowest risk. 

ICICI Pru Balanced Advantage has an in-house valuation-based model to decide hedging and equity allocations. The average net equity (equity not hedged through derivatives) has averaged around 40% in the past 2 years, much lower than the category average of 55%. However, the fund can reduce net equity quite significantly when markets trend towards the expensive or overheated zone; in November 2022, for example, net equity was just 32%. It can also quickly bring this back up if markets correct. In the 6-8 months following the 2020 correction, the fund had low hedging to make the most of the rally. It similarly upped equity exposure from April this year to above 40%.

ICICI Pru Balanced Advantage, thus, has far better downside containment than its category. Instances of losses in 1-month periods over the past 3 years is also lower at 25% compared to the 30% for the category average. Thanks to its strong downside containment and deft handling of market movements, the fund still manages above-average returns. 

On a rolling 1-year basis, the fund beats the category average 73% of the time even as the category includes aggressive funds that can deliver far higher returns. The fund also delivers better risk-adjusted returns.

Suitability: The fund needs a minimum holding period of 1.5-2 years. ICICI Pru Balanced Advantage suits investors looking for a lower-risk option with the aim of bringing down portfolio risk in long-term portfolios. It can also serve as a part-debt replacement for those looking for tax efficiency in long-term portfolios. In short-term portfolios of 2-3 years, it can be used by high-risk investors who want higher returns – combine this fund along with debt funds (or fixed deposits) to balance risk and returns. 

#2 Edelweiss Balanced Advantage

This fund is among the more aggressive in the category, and is listed in the Hybrid – Moderate Risk section in Prime Funds. In the past year, for example, the fund has kept derivative exposure below 10%. The average net equity is well above the category average at 72%. The fund maintains a high open equity exposure when markets are conducive and invests across market capitalisations. It can step up hedging when markets call for it, though; it was on the higher side in mid-2021, for example, after the rapid Covid rally.

As a result, Edelweiss Balanced Advantage clocks higher returns. It beats the category about 68% of the time on a rolling 1-year return basis over the past 3 years. Its margin of outperformance over the category has gone up to even 9-10 percentage points. Of course, owing to its aggressive nature, it falters on downsides where it scores in lowest quartile. Both volatility and propensity to slip into losses is higher in this fund than in others. However, the fund does still manage to use the upsides to deliver above-average risk-adjusted returns.

Suitability: The fund needs a minimum holding period of 2-3 years. Edelweiss Balanced Advantage is better-suited to add return potential to a portfolio without upping risk by much. That is, for investors with long-term portfolios who would like to increase equity allocation for the return potential can opt for Edelweiss Balanced Advantage instead of adding pure equity funds. The fund will be especially useful in larger portfolios to add diversification. More conservative investors can avoid using this fund in short-term portfolios. This fund would also be less suitable as a replacement for the debt component of a portfolio than ICICI Pru Balanced Advantage above.

#3 HDFC Balanced Advantage

This fund is among the more aggressive in the category, and is listed in the Hybrid – Moderate Risk section in Prime Funds. The fund was earlier HDFC Prudence, one of HDFC AMC’s two balanced funds. In the recategorization exercise, it moved into the balanced advantage category but retained both its portfolio and strategy that it had run with, until then. 

That is, the fund uses debt to balance out the equity risk instead of a derivative-debt combination. Further, it takes active calls in debt, moving between accrual and duration which most balanced advantage funds don’t normally do. HDFC Balanced has, in the past few quarters, begun to use small allocations to derivatives to reduce risk. But this remains significantly below peers and the fund continues to primarily use debt to counter equity risk; in this aspect it differs from most peers. In the past 12 months, the average net equity exposure was about 60%. But derivatives were only about 7-10%. The remaining portfolio has been held in a combination of corporate and government bonds. 

As a result, the fund is more aggressive than any of its peers. This has led to bigger losses during market corrections, which impacted overall returns as well as volatility. This apart, in periods such as 2020 to early 2021, the fund’s equity portfolio also underperformed in terms of stock and sector calls; a similar performance dip also showed up in HDFC’s other hybrid and equity funds.

However, returns have since picked up and the fund has clocked sustained outperformance over the past several quarters. HDFC Balanced Advantage has markedly improved consistency in beating category average to 87% of the time now, on a rolling 1-year return basis over the past 3 years. The strong performance of its equity portfolio, as well as timely calls on the debt side, has also sent average returns to the top of the charts. 

Do note that the fund continues to be a highly volatile performer and does not match up to peers in downside containment. Of course, now that HDFC Balanced Advantage has begun to undertake at least some hedging, it could increase this when markets correct – but this remains to be seen.

Suitability: The fund needs a minimum holding period of above 3-4 years. As with the Edelweiss fund above, HDFC Balanced Advantage is a good option to add equity in a portfolio without going for a pure equity fund. In this sense, it should be used like you would an aggressive hybrid fund. The fund would be unsuitable as a replacement for the debt component of a portfolio; it needs to be seen as a lower-risk equity option alone. The fund is also a good fit for those with smaller-sized portfolios or beginner investors who will otherwise find it hard to manage asset allocation using separate equity and debt funds.

The 3 funds mentioned above have varying degrees of risk as mentioned in the suitability. You may pick what suits you the most. And if you already have a BA/DAA fund that is a 'BUY' in our Portfolio Review Pro tool outside of these funds, you need not switch. Do not also switch your debt allocation in to these funds.

General disclaimers & disclosures

More like this

19 thoughts on “Prime Fund Recommendation: 3 balanced advantage funds for your portfolio”

  1. Hello,

    At this juncture of market at all time high does it make more sense to invest in these funds? Yes can have some part of debt category in these funds. I am low on equity and need to increase equity exposure, but with equity at all time high, with that respect does it make sense to invest in SIP equity or in these until market corrects?

    1. Bhavana Acharya

      You can invest in these funds if you want lower-risk equity options in your portfolio. But as explained in the post above, you need to have a minimum timeframe for these and they need to remain a part of your portfolio. They are not short-term parking options for a quick switch into equity. If markets correct, because these funds will also be impacted; they will just fall much lesser than pure equity. But if you have a timeframe of at least 5 years or longer from now and you’re very under-invested in equity you can still make normal SIP investments in equity funds and make sure you run the SIP through a correction. – thanks, Bhavana

  2. This is a brilliant article. Very clear and to the point. Ms Bhavana has clearly captured small investors concerns/requirement and addressed them in this article. Request to write a similar on Asset allocation. Asset Allocation suggest selling equity once threshold is reached even though one has 10 Yrs plus for the goals. Will this not be against Long term investing / compounding strategy

    1. Thanks. When your equity allocation is much higher than what you planned, then you need to bring it back in line so that your portfolio remains in sync with your risk and timeframe. Doing so amounts to booking profits and is not detrimental to your overall growth. Please note that you are not exiting equity – you are just bringing it down to what it should be for you. Rebalancing can be done both by redeeming from some funds and reinvesting or by investing afresh. You can use our rebalancing calculator. Please read this article as well, to understand rebalancing – https://www.primeinvestor.in/varsity/how-to-rebalance-your-portfolio/ – regards, Bhavana

  3. Hi Bhavana, thanks for the article.
    My understanding is that Edelweiss BAF is a “pro-cyclical” fund, where it increases equity exposure in a rising market. Icici Pru BAF does exactly the opposite, buying cheap and selling when markets are high.
    Is this TRUE, and how does this affect performance.

    1. Upping equity exposure will simply make the fund more aggressive & volatile, with potential for higher returns (due to higher equity exposure for longer) and less downside protection. – thanks, Bhavana

  4. I would request you to kindly compare other funds also like TATA, Kotak on a risk adjusted basis. What about upside/downside capture ratio?
    Would give far better picture.

    1. Tata scores well on all parameters, it is a Buy in our review tool. We have not added it to Prime Funds because it does not offer any specific advantage over the funds already in the list and it is a comparatively new fund and has not seen the market cycles the others have. Kotak scores below Tata and the other funds in terms of consistency and risk adjusted return. In terms of downside & volatility, IPru BA does better. – thanks, Bhavana

      1. Ganesan Rajagopal

        I prefer Tata Balanced Advantage Fund because it also has good downside protection (granted, with limited history) and the lowest expense ratio.

        1. Sure. As mentioned in the article, you can invest in BA/DAA funds that are a Buy in our Review Tool as well. – thanks, Bhavana

  5. Hi Ma’am,
    Thank you for the detailed and insightful article. Very helpful.

    Can i invest lumpsum or go for SIP in these funds? I can’t find this information in the fund recommendation page also.

    1. Either’s fine – choose based on what is convenient for you. If SIP is easier for you to manage, go with it. These funds aren’t as volatile as pure equity, so spreading investments to reduce timing risks is not absolutely necessary. You will also have the room to make more than one lumpsum investment over the course of time, since the two more aggressive funds need a 2-3 year holding – so you will still be able to address any risk that may come up even investing lumpsum. – thanks, Bhavana

  6. Hi Bhavana,

    I had invested in ICICI Balanced Adv Fund from 2017 to 2020. During Covid, after three years of SIPs, it was down 20-25 %, similar to equity funds. Thus in my view, it wasn’t a good fund.. I was disappointed and got rid of the fund.

    Further, FAs in these funds, tend to hide higher risk papers, to increase return. There’s no mention in your article. Value Research in its premium acct recommends Aggressive Equity Hybrid funds x 2, ICICI & SBI, in its higher savings income portfolio for more than 7 years duration, for my age.

    Besides, thanks for this excellent timely article.

    1. At the time (2019-20), I Pru Balanced advantage was much more aggressive than it is today; we had it in the Moderate Risk category in Hybrid earlier. It has since toned down. With regard to credit risk, most funds do not take credit calls. A few do have papers below AA+, but the total exposure is less than 2-3%, with individual issuers even lower, and is thus not significant to call out specifically as a risk. – thanks, Bhavana

  7. madhavan.sridharan1969

    Hi
    A request
    Since there are a number of funds with the same name in that find house, if you can provide the ISIN number for regular fund growth would be very useful while searching
    This would be a great help, if possible
    Madhavan

    1. Fund names are individual; there’s no two funds with the same name. It’s extremely rare for investors to search for funds using ISIN 🙂 it’s not easily available info – it’s usually easier to search by name. Platforms also do not give this as a search or filter field, for this reason. – thanks, Bhavana

Comments are closed.

Hold On

You are being redirected to another page,
it may take a few seconds.
Login to your account
OR

Become a PrimeInvestor!

Get stock & mutual fund recommendations

Start registration

Start registration

OR
user icon
user icon
user icon

Terms & Conditions

A copy of the T&C has been sent to your email.

Last modified on February 18, 2025

This website www.primeinvestor.in (“Website”) is owned and operated by PrimeInvestor Financial Research Pvt. Ltd. (“RA”), a SEBI-registered Research Analyst with Registration No. INH200008653.

Through the Website, the RA allows clients to access research recommendations, research reports, and model portfolios, along with tools, personal finance products, and articles, on the payment of a subscription fee (“Research Services”). The terms ‘RA’ or ‘us’ or ‘we’ refer to PrimeInvestor Financial Research Pvt Ltd (SEBI RA Registration No INH200008653) who are the owners of this Website and offering the Research Services. The term ‘you’ and ‘client’ refers to the subscriber of the Services on the Website. The RA provides the Research Services subject to the notices, terms, and conditions set forth in these Terms. By accepting these Terms when you subscribe to the Research Services, you provide your consent to abide by these Terms.

Most Important Terms and Conditions (MITC)

[Forming part of the Terms and Conditions for providing research services]

  1. These terms and conditions, and consent thereon are for the research services provided by the Research Analyst (RA) and RA cannot execute/carry out any trade (purchase/sell transaction) on behalf of the client. Thus, the clients are advised not to permit RA to execute any trade on their behalf.
  2. The fee charged by RA to the client will be subject to the maximum amount prescribed by SEBI/ Research Analyst Administration and Supervisory Body (RAASB) from time to time (applicable only for Individual and HUF Clients).
    Note:
    • SEBI's current cap on fee is Rs 1,51,000/- per annum per family of client for all research services of the RA.
    • The fee limit does not include statutory charges.
    • The fee limits do not apply to a non-individual client / accredited investor.
  3. RA may charge fees in advance if agreed by the client. Such advance shall not exceed the period stipulated by SEBI; presently it is one quarter. In case of pre-mature termination of the RA services by either the client or the RA, the client shall be entitled to seek refund of proportionate fees only for the unexpired period.
  4. Fees to RA may be paid by the client through any of the specified modes like cheque, online bank transfer, UPI, etc. Cash payment is not allowed. Optionally the client can make payments through Centralized Fee Collection Mechanism (CeFCoM) managed by BSE Limited (i.e. currently recognized RAASB).
  5. The RA is required to abide by the applicable regulations/ circulars/ directions specified by SEBI and RAASB from time to time in relation to disclosure and mitigation of any actual or potential conflict of interest. The RA will endeavor to promptly inform the client of any conflict of interest that may affect the services being rendered to the client.
  6. Any assured/guaranteed/fixed returns schemes or any other schemes of similar nature are prohibited by law. No scheme of this nature shall be offered to the client by the RA.
  7. The RA cannot guarantee returns, profits, accuracy, or risk-free investments from the use of the RA's research services. All opinions, projections, estimates of the RA are based on the analysis of available data under certain assumptions as of the date of preparation/publication of research report.
  8. Any investment made based on recommendations in research reports are subject to market risks, and recommendations do not provide any assurance of returns. There is no recourse to claim any losses incurred on the investments made based on the recommendations in the research report. Any reliance placed on the research report provided by the RA shall be as per the client's own judgement and assessment of the conclusions contained in the research report.
  9. The SEBI registration, Enlistment with RAASB, and NISM certification do not guarantee the performance of the RA or assure any returns to the client.
  10. For any grievances,
    • Step 1: the client should first contact the RA using the details on its website or following contact details:
      Customer care: [email protected]
      Grievance officer: [email protected], ATTN: Srikanth Meenakshi
      Compliance officer: [email protected], ATTN.: Bhavana Acharya
      Principal officer: [email protected], ATTN.: Vidya Bala
    • Step 2: If the resolution is unsatisfactory, the client can also lodge grievances through SEBI's SCORES platform at www.scores.sebi.gov.in
    • Step 3: The client may also consider the Online Dispute Resolution (ODR) through the Smart ODR portal at https://smartodr.in
  11. Clients are required to keep contact details, including email id and mobile number/s updated with the RA at all times.
  12. The RA shall never ask for the client’s login credentials and OTPs for the client’s Trading Account, Demat Account, and Bank Account. Never share such information with anyone including RA.

By browsing, viewing, using the Website and subscribing to the Research Services provided therein you consent to and agree to comply with these Terms and Conditions of subscription (“Terms”).

The RA reserves the right to change or modify the Website, the contents thereof and these Terms at any time. All modifications to these Terms & Conditions will be posted on the Website and will become effective immediately upon such posting. Changes once made will be communicated to the client. Continued use of the Website shall be construed as acceptance of the revisions to the Terms by conduct.

The following terms and conditions include but are not limited to minimum mandatory terms and conditions to clients as stipulated by SEBI.

1. Availing the research services

By accepting delivery of the research service, the client confirms that he/she has elected to subscribe to the research service of the RA at his/her sole discretion. The RA confirms that Research Services shall be rendered in accordance with the applicable provisions of the SEBI RA Regulations.

2. Obligations on RA

The RA shall be bound by the SEBI Act and all the applicable rules and regulations of SEBI, including the RA Regulations and relevant notifications of Government, as may be in force, from time to time.

3. Client Information and KYC

The client shall furnish all such details in full as may be required by the RA in its standard form with supporting details, if required, as may be made mandatory by Research Analyst Administration and Supervisory Body(RAASB)/SEBI from time to time. RA shall collect, store, upload and check KYC records of the clients with KYC Registration Agency (KRA) as specified by SEBI from time to time.

4. Standard Terms of Service

The consent of client shall be taken on the following understanding:

“I / We have read and understood the terms and conditions applicable to a research analyst as defined under regulation 2(1)(u) of the SEBI (Research Analyst) Regulations, 2014, including the fee structure.

I/We are subscribing to the research services for our own benefits and consumption, and any reliance placed on the research report provided by research analyst shall be as per our own judgement and assessment of the conclusions contained in the research report.

I/We understand that –

  1. Any investment made based on the recommendations in the research report are subject to market risk.
  2. Recommendations in the research report do not provide any assurance of returns.
  3. There is no recourse to claim any losses incurred on the investments made based on the recommendations in the research report.”

The declaration of the RA is as follows:

  1. We are duly registered with SEBI as an RA pursuant to the SEBI (Research Analysts) Regulations, 2014 and our registration details are: registration no SEBI INH200008653, with registration date 19th August, 2021
  2. We have the registration and qualifications required to render the services contemplated under the RA Regulations, and the same are valid and subsisting;
  3. Research analyst services provided by us do not conflict with or violate any provision of law, rule or regulation, contract, or other instrument to which it is a party or to which any of its property is or may be subject;
  4. The maximum fee that may be charged by the RA is ₹1.51 lakhs per annum per family of client. Our current fee structure, the term and duration of our subscription for our Research Services, can be viewed on our website here: https://primeinvestor.in/prime-pricing
  5. The recommendations provided by us as part of the Research Services do not provide any assurance of returns.

5. Consideration and mode of payment

The client shall duly pay to the RA the agreed fees for the services that RA renders to the client and statutory charges, as applicable. Such fees and statutory charges shall be payable through the specified manner and mode(s)/ mechanism(s).

The payment of fees shall be through a mode that shows traceability of funds. Such modes include but are not limited to credit cards/debit cards/ UPI/ net banking or any other mode specified by SEBI from time to time. However, the fees shall not be in cash.

6. Risk factors

  1. Investments are subject to market risk. Investing or trading in financial products involves risk. Past performance of the recommendation is not an indication of future returns. Past performance of the RA is not an indicator of future performance. Past performance of the security is not an indication of future returns.
  2. There are no assurances or guarantees that the objectives of any investment in financial products will be achieved.
  3. The names of financial products mentioned herein do not in any manner indicate their prospects or returns. The performance in the equity may be adversely affected by the performance of individual companies, changes in the market place and industry specific and macro-economic factors.
  4. The performance of the investments/ products recommended by the RA are subject to a wide range of risks, including but not limited to: performance of the respective companies, changes in equity and debt market conditions, micro and macro factors and forces affecting equity and debt markets, general levels of interest rates and interest rate risk, credit risk, liquidity risk, reinvestment risk, economic slowdown, volatility & illiquidity of the stocks, risks associated with trading volumes, liquidity and settlement systems in equity and debt markets and/or such other circumstance beyond the control of the RA or any of its Associates.
  5. Other risk factors include that may affect the performance of the investments/ products recommended by the RA include but are not limited to economic policies, changes of Government and its policies, acts of God, acts of war, civil disturbance, sovereign action and /or such other acts/ circumstance beyond the control of the RA or any of its Associates.
  6. The recommendations provided by the RA as part of its Research Services may not be suitable to all categories of investors.
  7. The client should read all scheme and security related documents carefully before investing.
  8. Returns and performance figures mentioned in the research report represent past performance and should not be constituted to be future returns or guaranteed returns.

7. Conflict of interest

The RA shall adhere to the applicable regulations/ circulars/directions specified by SEBI from time to time in relation to disclosure and mitigation of any actual or potential conflict of interest. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

General disclosures: PrimeInvestor Financial Research Pvt Ltd (with brand name PrimeInvestor) is an independent research entity offering research services on personal finance products to customers. We are a SEBI registered Research Analyst (Registration: INH200008653). PrimeInvestor Financial Research Pvt. Ltd., its employees, directors or agents, do not have any material adverse disciplinary history as on the date of publication of this report.

Restrictions on trading: To ensure no conflict of interest, the RA declares as follows:

  1. Personal trading activities of the individuals employed as research analysts shall be monitored, recorded and subject to a formal approval by the directors or compliance officer of PrimeInvestor Financial Research Private Limited.
  2. Research analysts employed by PrimeInvestor Financial Research Private Limited or their associates or relatives shall not:
    • Deal/ trade in stocks recommended/ tracked by the research analyst within 30 days before and five days after the publication of a research report;
    • Deal/ trade in securities that the research analyst reviews in a manner contrary to the given recommendation;
    • Purchase or receive securities of the issuer before the issuer's initial public offering, if the issuer is principally engaged in the same types of business as companies that the research analyst follows or recommends.

Disclosures with respect to Research and Recommendations Services:

  1. The RA or its directors or any of its officer/employee does not trade in securities which are subject matter of recommendation.
  2. The RA, or any of its officers, directors, employees, or subsidiaries have not received any compensation/ benefits whether monetary or in kind, from the AMC, company, government, bank or any other product manufacturer or third party, whose products are the subject of its Research Services or investment information.
  3. The Research Analysts who have prepared the research reports that form part of the Research Services (“Research Analyst”) certify that all of the views expressed in the research report accurately reflect their views about the subject company or subject security.
  4. The RA or directors or employees or Research Analyst certify that no part of their compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report.
  5. The Research Analyst has not served as director, officer or employee in the subject company, AMC or insurance company of the mutual fund or insurance policy that is the subject of this report, or company whose bonds, NCDs, fixed deposits or other savings products that is the subject of this report.
  6. The Research Analyst or their relatives do not have any known direct or indirect material conflict of interest including long/short positions in the subject company.
  7. The Research Analyst may hold investments in the stocks, mutual fund schemes, bonds, fixed deposits, insurance policies, or other products that are the subject of the recommendations provided as part of the Research Services. The Research Analyst certifies that they will not act in a manner contrary to their views on these securities except in the event of significant news or event or change in personal financial circumstances and without formal approval from the directors of PrimeInvestor Financial Research Pvt. Ltd. or the compliance officer.
  8. There are no actual or potential conflicts of interest arising from any connection to or association with any issuer of products/ securities, including any material information or facts that might compromise its objectivity or independence in the carrying on of the Research Services. Such conflict of interest shall be disclosed to the client as and when they arise.
  9. The RA or its directors or its employee or its associates have not managed or co-managed the public offering of any company. The RA or its directors or its employee or its associates have not received any compensation for investment banking or merchant banking of brokerage services from the subject company. The RA or its directors or its employee or its associates have not received any compensation for products or services other than above from the subject company. The RA or its directors or its employee or its associates have not received any compensation or other benefits from the Subject Company or 3rd party in connection with the research report/ recommendation.
  10. The subject company of its research recommendations was not a client of the RA or its directors or its employee or its associates during twelve months preceding the date of recommendation services provided.
  11. The RA or its directors or its employee or its associates has not served as an officer, director or employee of the subject company. Research Analysts has not been engaged in market making activity of the subject company.

PrimeInvestor Financial Research Pvt. Ltd., its Associates, the Research Analysts or their relatives holds ownership of 1% or more, in respect of the said issuer company(ies)? – NO

8. Termination of service and refund of fees:

The RA may terminate or suspend rendering of Research Services to the client in the following circumstances:

  1. On account of suspension/cancellation of registration of RA by SEBI. In case of suspension of certificate of registration of the RA for more than 60 (sixty) days or cancellation of the RA registration, RA shall refund the fees, on a pro rata basis for the period from the effective date of cancellation/ suspension to end of the client’s subscription period.
  2. The RA voluntarily chooses to terminate its Research Service. In the event of such termination of the Research Service, the RA shall refund the fees, on a pro rata basis for the period from the date of such termination of research service to end of the client’s subscription period.

9. Grievance redressal and dispute resolution:

Any grievance related to:

  1. nonreceipt of research report, or
  2. missing pages or inability to download the entire report, or
  3. any other deficiency in the research services provided by RA

shall be escalated promptly by the client to the person/employee designated by RA, in this behalf as under:

Name: Bhavana Acharya
Designation: Director & Compliance Officer, PrimeInvestor Financial Research Pvt Ltd
Email: [email protected]

The RA shall be responsible to resolve grievances within 7 (seven) business working days or such timelines as may be specified by SEBI under the RA Regulations.

RA shall redress grievances of the client in a timely and transparent manner. Any dispute between the RA and his client may be resolved through arbitration or through any other modes or mechanism as specified by SEBI from time to time.

If the client is not satisfied with the response of the RA, he/she can lodge his/her grievances with SEBI at scores.sebi.gov.in. Alternatively, the client may also write to any of the offices of SEBI. For any queries, feedback or assistance, please contact SEBI Office on Toll Free Helpline at 1800 22 7575 / 1800 266 7575

Details on grievances are available on the Website as follows: https://primeinvestor.in/ra-grievance/

10. Additional clauses:

Scope of the Research Service: The Research Services will be limited to providing independent research recommendation and shall not be involved in any advisory or portfolio allocation services. The Research Services are not meant to be tailor-made or customized solutions that specifically apply to each client based on his/her risk profile.

The RA never guarantees the returns on the recommendation provided. Investor shall take note that investment/trading in stocks/Index or other securities is always subject to market risk. Past performance is never a guarantee of same future results. The RA shall not be responsible for any loss to the Investors.

This service is not directed for access or use by anyone in a country, especially the USA, Canada or the European Union countries, where such use or access is unlawful or which may subject PrimeInvestor Financial Research Pvt Ltd or its affiliates to any registration or licensing requirement.

The Research Service, including recommendations, research reports, updates, and other information will be accessible through the RA’s website https://primeinvestor.in only. Such recommendations and updates will not be provided over phone calls.

Fees: Our current fee structure, the term and duration of our subscription for our Research Service, can be viewed on our website: https://primeinvestor.in/prime-pricing. Eligibility for any discounts is ascertained at the time the client subscribes. Any such discount and its tenure shall be at the discretion of the RA.

Subscription and access to content services fall under the purview of Goods and Services Tax (GST) as per the current indirect taxation policy, Government of India. Unless otherwise indicated, prices stated on our website are exclusive of applicable GST, any applicable value added tax (VAT) or other sales taxes. We are a business-to-consumer (B2C) service provider and we do not commit to provide any input tax credit on GST charged on subscription to our Research Service.

We may change the Subscription Fees and charges then in effect, or add new fees or charges which will take effect at the end of the client’s subscription period, by giving notice in advance and an opportunity to cancel renewal of the subscription.

Subscription Access & Renewal: Subscription to the Website commences immediately on the realisation of payment of the Subscription Fees. Subscriptions are set to be renewed automatically at the end of the subscription period.

Unless the client notifies us before the end of his/her subscription period, or the client cancels the auto-renewal mandate within the period specified by law, that the client does not wish to renew his/her subscription, the client’s subscription will renew for the period defined by the client’s subscription plan. We will charge the subscription using the same payment method that you previously used.

Although the client may notify to us his/her intention to his/her subscription, such notice will only take effect at the end of his/her then current subscription period, and he/she will not receive a refund other than as set out under Clause 8 in these Terms.

The client may notify us of his/her wish to cancel his/her subscription by sending an email to [email protected]. The client must provide at least 5 business days advance notice for this to be implemented.

Refunds: There can be no cancellation and refund of subscription fee paid once the subscription is active, other than as stated in Clause 8 of these Terms. If the client is entitled to a refund as specified under Clause 8 of these Terms, the RA will credit that refund to the card or other payment method used by the client to submit payment, unless it has expired - in which case the RA will contact the client to proceed with the refund. If we do issue a refund or credit due to circumstances outside the obligations specified under Clause 8, we are under no obligation to issue the same or a similar refund in the future.

General disclaimers: The recommendations made herein in the Research Services are expression of views and/or opinions and should not be deemed or construed to be advice for the purpose of purchase or sale of any security, nor a solicitation or offering on any investment/ trading opportunity on behalf of the company, AMC, insurance company, or issuer of security referred to herein.

The content and research reports generated by the RA does not constitute or is not intended to constitute an offer to buy or sell, or a solicitation to an offer to buy or sell financial products, units or securities.

The information/ opinion/ views mentioned in research reports or by the RA are not meant to serve as a professional guide to the client or recipients of this Report. The research report, recommendation, or any other content published by the RA do not assure or guarantee any minimum or fixed returns to the client or recipients of the reports/ recommendations/ content.

Use of this information is at the client’s own risk. The client must make his/ her own investment decisions based on his/her specific investment objective and financial position and using such independent advisors as he/she believes necessary. The services rendered by the RA are on a best-effort basis. All information in the content or research report of the RA is provided on an as is basis. Information is believed to be reliable but the RA does not warrant its completeness or accuracy and expressly disclaim all warranties and conditions of any kind, whether express or implied.

While due care has been taken to ensure that the disclosures, information, and opinions given are fair and reasonable, PrimeInvestor Financial Research Pvt Ltd and/or none of its officers, directors, partners, employees, agents, subsidiaries, affiliates or business associates shall be liable for any direct, indirect, special, incidental, consequential, punitive or exemplary damages, including lost profits arising in any way whatsoever from the information/ opinions/ views contained in the research report and recommendations that form part of the Research Service, and/or mails, social media or notifications issued by PrimeInvestor Financial Research Pvt Ltd or any other agency appointed/authorised by PrimeInvestor Financial Research Pvt Ltd. Returns and performance figures mentioned in the research report represent past performance and should not be constituted to be future returns or guaranteed returns.

Any agreements, transactions or other arrangements made between the client and any third party named on (or linked to from) the Website are at your own responsibility and entered into at your own risk. Any information that you receive via the Website, whether or not it is classified as “real time”, may have stopped being current by the time it reaches you. Market price information may be rounded up/down and therefore may not be entirely accurate.

The purpose of these disclosures is to provide essential information about the Research Services in a manner to assist and enable the prospective client/client in making an informed decision for engaging in Research Services before onboarding.

History, present business and background: PrimeInvestor Financial Research Private Limited is registered with SEBI as Research Analyst with registration no. INH200008653. The Research Analyst got its registration on August 19, 2021 and is engaged in offering research and recommendation services.

Disciplinary history: There are no pending material litigations or legal proceedings against the Research Analyst. As on date, no penalties / directions have been issued by SEBI under the SEBI Act or Regulations made thereunder against the Research Analyst relating to Research Analyst services.

Details of the RA's associates: No associates.

Usage of Website Content: This Website is controlled and operated by the RA. All material, including research reports, recommendations, portfolios, ratings, lists of financial products, illustrations, statements, opinions, views, photographs, products, images, artwork, designs, text, graphics, logos, button icons, images, audio and video clips and software (collectively, “Content”) are protected by copyrights, trademarks and other intellectual property rights that are owned and controlled by the RA or by other parties that have licensed their material to us.

Except where otherwise agreed in writing with the RA, material on the Website is solely for the client’s personal, non-commercial use. Except as provided below, the client must not copy, reproduce, republish, upload, post, transmit or distribute such material in any way, including by e-mail or other electronic means and whether directly or indirectly and the client must not assist any other person to do so.

Without the prior written consent of the RA, modification of the materials, use of the materials on any other web site or networked computer environment or use of the materials for any purpose other than personal, non-commercial use is a violation of the copyrights, trademarks and other proprietary rights, and is prohibited. Any use for which the client receives any remuneration, whether in money or otherwise, is a commercial use for the purposes of these Terms.

The client may occasionally distribute a copy of a research report, or a portion of the same, from the Website in non-electronic form to a few individuals without charge, provided the client includes all copyright and other proprietary rights notices in the same form in which the notices appear, original source attribution, and the phrase “Used with permission from PrimeInvestor Financial Research Pvt. Ltd.”

While the client may occasionally download and store research reports or information from the Website for his/her personal use, he/she may not otherwise provide others with access to the same. The foregoing does not apply to any sharing functionality we provide through the Website that expressly allows the client to share Content or links to Content with others. In addition, the client may not use Content he/she has downloaded for personal use to develop or operate an automated trading system or for data or text mining.

The client agrees not to rearrange or modify the Content available through the Website. The client agrees not to display, post, frame, or scrape the Content for use on another website, app, blog, product or service, except as otherwise expressly permitted by these Terms. You agree not to create any derivative work based on or containing the research products and Content. The framing or scraping of or in-line linking to the Services or any Content contained thereon and/or the use of webcrawler, spidering or other automated means to access, copy, index, process and/or store any Content made available on or through the Services other than as expressly authorized by us is prohibited.

The client further agrees to abide by exclusionary protocols (e.g., Robots.txt, Automated Content Access Protocol (ACAP), etc.) that may be used in connection with the Research Services. The client may not access parts of the Research Services to which he/she is not authorized, or attempt to circumvent any restrictions imposed on your use or access of the Services.

As a general rule, the client may not use the Content, including without limitation, any Content made available through one of our RSS Feeds, in any commercial product or service, without our express written consent.

The client may not create apps, extensions, or other products and services that use our Content without our permission. The client may not aggregate or otherwise use our Content in a manner that could reasonably serve as a substitute for a subscription to the Website.

The client may not access or view the Services with the use of any scripts, extensions, or programs that alter the way the Services are displayed, rendered, or transmitted to you without our written consent.

The client agrees not to use the Services for any unlawful purpose. We reserve the right to terminate or restrict the client's access to the Website if, in our opinion, the client's use of the Services may violate any laws, regulations or rulings, infringe upon another person's rights or violate these Terms.

Prohibited content: The Website includes comments sections, blogs and other interactive features that allow interaction among clients and between clients and the RA. We call the information posted by or contributed by users “Contributed Content.” In the course of availing of the Research Services or uploading any post or comment on the Website, the client shall not post any Contributed Content that (i) contains nude, semi-nude, sexually suggestive photos, (ii) tends or is likely to abuse, harass, threaten, impersonate or intimidate other users of the Website and/or Research Services, (iii) is lascivious or appeals to the prurient interest or if its effect is such as to tend to deprave and corrupt persons who are likely to use or have access to the Website and/or Services, or (iv) otherwise violates, is prohibited or restricted by applicable law, rule or regulation, is offensive or illegal or violates the rights of, harms or threatens the safety of other users of the Website and/or Services (collectively “Prohibited Content”).

We reserve the right to cease to provide the client with the Research Services or access to the Website, or terminate your subscription, with immediate effect and without notice and liability, for violating these Terms, applicable law, rules or regulations and reserves the right to remove Prohibited Content which is in violation of these Terms, or is otherwise abusive, illegal or disruptive. The determination of whether any content constitutes Prohibited Content, violates these Terms, or is otherwise abusive illegal or disruptive, is subject to the sole determination of the Firm.

Changes to Research Services: We are constantly endeavouring to improve the quality of Research Services provided to our clients. Due to this, the form and nature of the Research Services provided may change from time to time without any prior notice to the client. We reserve the right to introduce and initiate new features, functionalities, components to the Website and/or Research Services and/or change, alter, modify, or discontinue existing ones without any prior notice to the client.

Warranty and liability disclaimer: The Website, Research Services, and all the materials and services, included on or otherwise made available to the client through this Website is provided by the RA on an “as is” and “as available” basis without any representation or warranties, express or implied except otherwise specified in writing. Without prejudice to the foregoing paragraph, the RA does not warrant that:

  • This Website and/or Research Services will be constantly available, or available at all;
  • The information on this Website or provided through the Research Services is complete, true, accurate or not misleading; or
  • The quality of any products, services, information, or other material that you obtain through the Website or Services will meet your expectations.

The RA, to the fullest extent permitted by law, disclaims all warranties, whether express or implied, including the warranty of merchantability, fitness for particular purpose and non-infringement. The RA makes no warranties about the accuracy, reliability, completeness, or timeliness of the Website, Research Services, Content, Contributed Content, Services, software, text, graphics and links.

The RA does not warrant that this Website, Research Services, information, content, materials, or any other material included on or otherwise made available to you through this Website, their servers, or electronic communication sent by the RA are free of viruses or other harmful components.

Nothing on this Website constitutes, or is meant to constitute, advice of any kind.

Indemnification: The client:

  1. Represents, warrants and covenants that no materials of any kind provided by him/her will:
    1. Violate, plagiarise, or infringe upon the rights of any third party, including copyright, trademark, privacy or other personal or proprietary rights; or
    2. Contain libellous, Prohibited Content or other unlawful material;
  2. Hereby agree to indemnify, defend and hold harmless the RA and all of the RA’s officers, directors, owners, agents, customers/clients, information providers, affiliates, licensors and licensees (collectively, the “Indemnified Parties”) from and against any and all liability and costs, including, without limitation, reasonable advocate’s fees, incurred by the Indemnified Parties in connection with any claim arising out of any breach by the client of these Terms or the foregoing representations, warranties and covenants. The client shall cooperate as fully as reasonably required in the defence of any such claim. The RA reserves the right, at its own expense, to assume the exclusive defence and control of any matter subject to indemnification by the client.

Applicable law: This Website, including the Content and Contributed Content and information contained herein, and the provision of Research Services shall be governed by the Securities and Exchange Board of India, laws of the Republic of India and the courts of Chennai, India which shall retain exclusive jurisdiction to entertain any proceedings in relation to any disputes arising out of the same. As such, the laws of India shall govern any transaction completed using this Website.

Information gathered and tracked: Information submitted or collected on the Website or pursuant to the use of the Services is stored in a database. Specifically, we store the username, name, e-mail address, contact number, as submitted or collected on our Website or through the provision of the Research Services. We may use such information to send out occasional promotional materials, including alerts on new Services available, or other promotional and marketing material relating to our clients and customers.

In accordance with the Information Technology Act 2000, the name and the details of the Grievance Officer at PrimeInvestor is provided below:

Mr. Srikanth Meenakshi
PrimeInvestor Financial Research Pvt. Ltd., Registered office: 659, 4th Avenue, D-Sector, Anna Nagar Western Extension, Chennai 600 101.
Email: [email protected]

11. Mandatory notice:

Clients shall be requested to go through Do’s and Don’ts while dealing with RA as specified in SEBI master circular no. SEBI/HO/MIRSD-POD-1/P/CIR/2024/49 dated May 21, 2024 or as may be specified by SEBI from time to time.

12. Optional Centralised Fee Collection Mechanism:

SEBI has operationalized a centralized fee collection mechanism for IA and RA. Under this mechanism, clients shall pay fees to IAs/RAs through a designated platform/portal administered by a recognized Administration and Supervision body. This is an optional mechanism for the registered entities. At this time, PrimeInvestor has opted out of this fee collection mechanism. Therefore, all subscription payments for the Research Services will be through the modes as specified in Clause 5 of these Terms.

Enter the OTP sent to (Edit)
By doing this you agree to our terms & conditions
Didn't receive OTP? Resend

Have an account?
Login To Your Account
OR
Don’t have an account ? Register for free